145 related articles for article (PubMed ID: 38637153)
1. Total fermentable oligo-, di-, monosaccharides and polyols intake, carbohydrate malabsorption and gastrointestinal symptoms during a 56 km trail ultramarathon event.
Convit L; Rahman SS; Jardine WT; Urwin CS; Roberts SSH; Condo D; Main LC; Carr AJ; Young C; Snipe RMJ
Nutr Diet; 2024 Jun; 81(3):335-346. PubMed ID: 38637153
[TBL] [Abstract][Full Text] [Related]
2. [Malabsorption of fermentable oligo-, di-, or monosaccharides and polyols (FODMAP) as a common cause of unclear abdominal discomfort].
Goebel-Stengel M; Mönnikes H
Dtsch Med Wochenschr; 2014 Jun; 139(24):1310-4. PubMed ID: 24892470
[TBL] [Abstract][Full Text] [Related]
3. Impact of 24-h high and low fermentable oligo-, di-, monosaccharide, and polyol diets on markers of exercise-induced gastrointestinal syndrome in response to exertional heat stress.
Gaskell SK; Taylor B; Muir J; Costa RJS
Appl Physiol Nutr Metab; 2020 Jun; 45(6):569-580. PubMed ID: 31652404
[TBL] [Abstract][Full Text] [Related]
4. A low fermentable oligo-di-mono-saccharides and polyols (FODMAP) diet is a balanced therapy for fibromyalgia with nutritional and symptomatic benefits.
Marum AP; Moreira C; Tomas-Carus P; Saraiva F; Guerreiro CS
Nutr Hosp; 2017 Jun; 34(3):667-674. PubMed ID: 28627205
[TBL] [Abstract][Full Text] [Related]
5. Applying a Low-FODMAP Dietary Intervention to a Female Ultraendurance Runner With Irritable Bowel Syndrome During a Multistage Ultramarathon.
Gaskell SK; Costa RJS
Int J Sport Nutr Exerc Metab; 2019 Jan; 29(1):61-67. PubMed ID: 29757053
[TBL] [Abstract][Full Text] [Related]
6. The impact of 48 h high carbohydrate diets with high and low FODMAP content on gastrointestinal status and symptoms in response to endurance exercise, and subsequent endurance performance.
Scrivin R; Slater G; Mika A; Rauch C; Young P; Martinez I; Costa RJS
Appl Physiol Nutr Metab; 2024 Jun; 49(6):773-791. PubMed ID: 38359412
[TBL] [Abstract][Full Text] [Related]
7. Low fermentable oligo-di-mono-saccharides and polyols diet versus general dietary advice in patients with diarrhea-predominant irritable bowel syndrome: A randomized controlled trial.
Zahedi MJ; Behrouz V; Azimi M
J Gastroenterol Hepatol; 2018 Jun; 33(6):1192-1199. PubMed ID: 29159993
[TBL] [Abstract][Full Text] [Related]
8. [The diet low in fermentable carbohydrates short chain and polyols improves symptoms in patients with functional gastrointestinal disorders in Spain].
Huamán JW; Felip A; Guedea E; Jansana M; Videla S; Saperas E
Gastroenterol Hepatol; 2015 Mar; 38(3):113-22. PubMed ID: 25458546
[TBL] [Abstract][Full Text] [Related]
9. Hydrogen Breath Tests: Are They Really Useful in the Nutritional Management of Digestive Disease?
Usai-Satta P; Oppia F; Lai M; Cabras F
Nutrients; 2021 Mar; 13(3):. PubMed ID: 33802839
[TBL] [Abstract][Full Text] [Related]
10. Adding glucose to food and solutions to enhance fructose absorption is not effective in preventing fructose-induced functional gastrointestinal symptoms: randomised controlled trials in patients with fructose malabsorption.
Tuck CJ; Ross LA; Gibson PR; Barrett JS; Muir JG
J Hum Nutr Diet; 2017 Feb; 30(1):73-82. PubMed ID: 27600184
[TBL] [Abstract][Full Text] [Related]
11. Fermentable oligo-, di-, monosaccharides, and polyols (FODMAPs), but not gluten, elicit modest symptoms of irritable bowel syndrome: a double-blind, placebo-controlled, randomized three-way crossover trial.
Nordin E; Brunius C; Landberg R; Hellström PM
Am J Clin Nutr; 2022 Feb; 115(2):344-352. PubMed ID: 34617561
[TBL] [Abstract][Full Text] [Related]
12. A Retrospective Study on Dietary FODMAP Intake in Celiac Patients Following a Gluten-Free Diet.
Roncoroni L; Elli L; Doneda L; Bascuñán KA; Vecchi M; Morreale F; Scricciolo A; Lombardo V; Pellegrini N
Nutrients; 2018 Nov; 10(11):. PubMed ID: 30445688
[TBL] [Abstract][Full Text] [Related]
13. Gastrointestinal tolerance of low FODMAP oral nutrition supplements in healthy human subjects: a randomized controlled trial.
Erickson J; Korczak R; Wang Q; Slavin J
Nutr J; 2017 May; 16(1):35. PubMed ID: 28545589
[TBL] [Abstract][Full Text] [Related]
14. A low fermentable oligo-di-mono saccharides and polyols (FODMAP) diet reduced pain and improved daily life in fibromyalgia patients.
Marum AP; Moreira C; Saraiva F; Tomas-Carus P; Sousa-Guerreiro C
Scand J Pain; 2016 Oct; 13():166-172. PubMed ID: 28850525
[TBL] [Abstract][Full Text] [Related]
15. Effect of a short-term low fermentable oligiosaccharide, disaccharide, monosaccharide and polyol (FODMAP) diet on exercise-related gastrointestinal symptoms.
Wiffin M; Smith L; Antonio J; Johnstone J; Beasley L; Roberts J
J Int Soc Sports Nutr; 2019 Jan; 16(1):1. PubMed ID: 30646926
[TBL] [Abstract][Full Text] [Related]
16. Carbohydrate Maldigestion and Intolerance.
Fernández-Bañares F
Nutrients; 2022 May; 14(9):. PubMed ID: 35565890
[TBL] [Abstract][Full Text] [Related]
17. Randomised clinical trial: low-FODMAP rye bread vs. regular rye bread to relieve the symptoms of irritable bowel syndrome.
Laatikainen R; Koskenpato J; Hongisto SM; Loponen J; Poussa T; Hillilä M; Korpela R
Aliment Pharmacol Ther; 2016 Sep; 44(5):460-70. PubMed ID: 27417338
[TBL] [Abstract][Full Text] [Related]
18. [Low Fermentable Oligo-, Di- and Monosaccharides and Polyols (FODMAP) diet in the treatment of patients with irritable bowel syndrome: basic principles and methodology].
Kuvaev RO; Yakovenko EP; Nikonov EL; Zaytsev SV; Pospelova EE; Krashenkova AV
Vopr Pitan; 2020; 89(6):38-47. PubMed ID: 33476497
[TBL] [Abstract][Full Text] [Related]
19. Presence of Fermentable Oligo-, Di-, Monosaccharides, and Polyols (FODMAPs) in commonly eaten foods: extension of a database to indicate dietary FODMAP content and calculation of intake in the general population from food diary data.
Liljebo T; Störsrud S; Andreasson A
BMC Nutr; 2020; 6():47. PubMed ID: 32963797
[TBL] [Abstract][Full Text] [Related]
20. The impact of dietary fermentable carbohydrates on a postinflammatory model of irritable bowel syndrome.
Tuck CJ; Caminero A; Jiménez Vargas NN; Soltys CL; Jaramillo Polanco JO; Lopez Lopez CD; Constante M; Lourenssen SR; Verdu EF; Muir JG; Lomax AE; Reed DE; Vanner SJ
Neurogastroenterol Motil; 2019 Oct; 31(10):e13675. PubMed ID: 31290223
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
